Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605708.8Aexternal-prioritypatent/GB9605708D0/en
Application filed by IndividualfiledCriticalIndividual
Priority claimed from PCT/US1997/001354external-prioritypatent/WO1997027852A1/fr
Publication of CA2243320A1publicationCriticalpatent/CA2243320A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La présente invention se rapporte à des composés qui inhibent la farnésyle transférase (Ftase) ainsi que la farnésylation de la protéine oncogène Ras. L'invention se rapporte en outre à des compositions chimiothérapeutiques contenant les composés de cette invention et à des procédés destinés à inhiber la farnésyle transférase ainsi que la farnésylation de la protéine oncogène Ras.
CA 22433201996-01-301997-01-27Inhibiteurs de la farnesyle transferase
AbandonedCA2243320A1
(fr)